AEMD

Aethlon Medical, Inc. · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website aethlonmedical.com
Employees(FY) 15
ISIN US00808Y4061

Performance

+58.56%

+49.29%

+48.72%

-14.07%

-73.52%

YTD

-69.15%

Profile

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.

Advanced Technical Analysis

Technical Analysis of AEMD 2024-12-20

The stock exhibits a strong bullish sentiment with a Moving Average Score of 83, indicating robust upward momentum, while the Technical Score of 70 further supports this positive outlook. However, the Oscillators Score of 56 suggests a more neutral stance, indicating potential consolidation or a pause in the upward trend.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of AEMD

Stock Rank

Recent News & Updates

2024-12-19 19:01
Aethlon Medical Provides Update on the Ability of Its Hemopurifier to Capture H5N1 Bird Flu(Prnewswire)
2024-12-03 18:00
Presenting on the Emerging Growth Conference 77 Day 2 on December 5th Register Now(Globenewswire)
2024-12-02 18:00
Presenting on the Emerging Growth Conference 77 Day 1 on December 4th Register Now(Globenewswire)
2024-11-13 19:00
Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally(Newsfilecorp)
2024-11-13 13:14
Aethlon Medical Inc (AEMD) Q2 2025 Earnings Call Highlights: Progress in Oncology Trials and ...(Yahoo Finance)
2024-11-13 03:15
Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update(Prnewswire)
2024-11-11 19:00
Innovative Medical Technology Advances with First Patient Enrollments(Newsfilecorp)
2024-11-10 22:18
Aethlon Medical enrols first patient in trial of Hemopurifier device for cancer(Yahoo Finance)
2024-11-10 19:01
Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier Cancer Trial in Australia(Prnewswire)
2024-11-05 19:01
Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024(Prnewswire)
2024-10-29 19:00
Presenting on the Emerging Growth Conference 76 Day 2 on October 31 Register Now(Globenewswire)
2024-10-28 19:00
Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now(Globenewswire)
2024-10-09 06:26
Aethlon Medical Inc (AEMD) Q1 2025 Earnings Call Highlights: Strategic Cost Management and ...(Yahoo Finance)
2024-10-07 20:01
Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit(Prnewswire)
2024-09-24 19:00
Presenting on the Emerging Growth Conference 75 Day 2 on September 26(Globenewswire)
2024-09-23 19:00
Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now(Globenewswire)
2024-09-19 20:35
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing(Yahoo Finance)
2024-09-18 22:00
Immunotherapy Clinical Trials - A New Approach to Treating Cancer(Newsfilecorp)
2024-09-18 20:01
Aethlon Receives Ethics Committee Approval for Hemopurifier Cancer Trial in India(Prnewswire)
2024-09-16 20:01
Aethlon Medical to Present at Virtual Investor Conferences in September(Prnewswire)
2024-09-16 15:30
Innovation Driving Cancer's Solid Tumors Market(Newsfilecorp)
2024-09-16 00:07
Life Sciences Virtual Investor Forum Agenda Announced for September 19th(Yahoo Finance)
2024-09-15 20:01
Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier Cancer Trial(Prnewswire)
2024-09-12 20:35
Aethlon Medical to Present at the Life Sciences Investor Forum September 19th(Yahoo Finance)
2024-08-26 20:01
Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys(Prnewswire)
2024-08-14 04:15
Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update(Prnewswire)
2024-08-12 18:53
Aethlon Medical receives ethics committee approval for trial of cancer treatment(Yahoo Finance)
2024-08-11 21:01
The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors(Newsfilecorp)
2024-08-11 20:01
Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier Cancer Trial(Prnewswire)
2024-08-05 21:12
Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024(Prnewswire)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.